Results 221 to 230 of about 10,050,452 (244)

Adaptive immunity of type VI CRISPR-Cas systems associated with reverse transcriptase-Cas1 fusion proteins. [PDF]

Nucleic Acids Res
Molina-Sánchez MD, Martínez-Abarca F, Millán V, Mestre MR, Stehantsev P, Stetsenko A, Guskov A, Toro N.   +7 more
europepmc   +1 more source

Correction to 'DNA target binding-induced pre-crRNA processing in type II and V CRISPR-Cas systems'. [PDF]

Nucleic Acids Res
europepmc   +1 more source

Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria

Nature Communications, 2017
International audienceType II CRISPR-Cas systems introduce double-strand breaks into DNA of invading genetic material and use DNA fragments to acquire novel spacers during adaptation.
Lun Cui, Alicia Calvo-Villamañán, Marie Touchon   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Alternative functions of CRISPR–Cas systems in the evolutionary arms race

Nature Reviews Microbiology, 2022
John van der Oost, Prarthana Mohanraju, Raymond Staals   +2 more
exaly  

RNA-targeting CRISPR–Cas systems

Nature Reviews Microbiology, 2022
Stan J J Brouns, Sam van Beljouw, Alicia Rodríguez-Molina   +2 more
exaly  

Structural biology of CRISPR–Cas immunity and genome editing enzymes

Nature Reviews Microbiology, 2022
Patrick Pausch, Jennifer Doudna, Joy Wang   +2 more
exaly  

Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors

Cell, 2022
Jennifer Doudna, Brian Staskawicz
exaly  

Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy

Advanced Drug Delivery Reviews, 2021
Siyan He, Xiangrong Song, Changyang Gong   +2 more
exaly